CASCIO, Paolo
CASCIO, Paolo
SCIENZE VETERINARIE
A new fluorogenic peptide determines proteasome activity in single cells
2011-01-01 S. Urru; P. Veglianese; A. De Luigi; S. Cenci; P. Cascio; M. Salmona
Alterations of the MCH class-I antigen presentation pathway in feline injection-site sarcoma (FISS)
2004-01-01 Cerruti F.; Petterino C.; Martano M.; Buracco P.; Bruno R.; Cascio P.
Analisi dell’attività proteasomale come marker per lo studio delle neoplasie
2010-01-01 F. Cerruti; M. Martano; E. Morello; P. Buracco; M. Massa; L. Rambozzi; P. Cascio
Assessing proteasome workload to predict response and overcome resistance to proteasome inhibitors in multiple myeloma
2007-01-01 G. Bianchi; A. Orsi; P. Cascio; D. Chauhan; K.C. Anderson; R. Sitia; S. Cenci
Assessing proteostasis and proteasome stress in light chain amyloidosis
2010-01-01 L. Oliva; F. Cerruti; N. Pengo; G. Palladini; P. Cascio; G. Merlini; R. Sitia; S. Cenci
Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress
2011-01-01 L. Oliva; G. Palladini; F. Cerruti; N. Pengo; P. Cascio; R. Sitia; G. Merlini; S. Cenci
BIOCHEMICAL CHARACTERIZATION OF 26S PROTEASOMES IN FARM ANIMALS TO IMPROVE KNOWLEDGE ABOUT ANTIGEN PROCESSING
2014-01-01 M. RAULE; F. CERRUTI; P. CASCIO
Catalytic, immunochemical and molecular characterization of xenobiotic-metabolising enzyme modulation by phenobarbital in the bovine liver
2006-01-01 M. CANTIELLO; M. CARLETTI; M. DACASTO; F. CAPOLONGO; G. GARDINI; P. CASCIO; P. G. P. MARTIN; T. PINEAU; C. NEBBIA
Comparative study of proteasomal enzymatic activities in farm animals to better understand biochemical mechanisms of antigen processing
2014-01-01 M. Raule; F. Cerruti; P. Cascio
Direct Assessment of Proteasomal Degradation as a Potential Predictor of Responsiveness to Bortezomib in Multiple Myeloma
2006-01-01 Bianchi G.; Orsi A.; Cenci S.; Cascio P.; Chauhan D.; Anderson K.C.; Sitia R
Doxorubicin treatment does not affect enhanced immunoproteasome expression and activities in feline-injection site sarcoma
2008-01-01 F. Cerruti; M. Martano; C. Petterino; E. Bollo; E. Morello; R. Bruno; P. Buracco; P. Cascio
Effect of the load versus capacity unbalance on the sensitivity of malignant pleural mesothelioma cells to proteasome inhibitors
2013-01-01 Jocollè, G.; Numico, G.; Cerruti, Fulvia; Oliva, L.; Cenci, S.; Donati, G.; Cascio, Paolo
Electron microscopy and functional studies reveal cellular stress in amyloidogenic plasma cells
2013-01-01 L. Oliva; A. Raimondi; F. Cerruti; P. Cascio; S. Casarini; G. Palladini; M. Marcatti; F. Ciceri; G. Merlini; S. Cenci
Electron microscopy and functional studies reveal cellular stress in amyloidogenic plasma cells
2013-01-01 L. Oliva; A. Raimondi; F.Cerruti; P. Cascio; S. Casarini; G. Palladini; M. Marcatti; F. Ciceri; G. Merlini; S. Cenci
Enhanced expression of gamma-interferon induced antigen processing machinery components in feline-injection site sarcoma
2008-01-01 Cerruti F.; Martano M.; Petterino C.; Bollo E.; Morello E.; Bruno R.; Buracco P.; Cascio P.
Generation of cellular and animal models to monitor the role of the unfolded protein response in development and genetic diseases
2005-01-01 R. Sitia; T. Anelli; G. Bertoli; P. Cascio; S. Cenci; C. Fagioli; A. Mezghrani; S. Nerini-Molteni; E. Pasqualetto; L. Tagliavacca
Identification of potential new MHC-I epitopes through in vitro proteasomal degradation of antigenic proteins
2012-01-01 Raule M.; Profiti M.; Cerruti F.; Dittmar G.; Rosati S.; Cascio P.
Imbalance between synthetic load and proteasomal capacity as the target of proteasome inhibitors in multiple myeloma
2005-01-01 S. Cenci; A. Mezghrani; P. Cascio; F. Cerruti; S. Masciarelli; L. Mattioli; L. Oliva; A. Orsi; E. Pasqualetto; E. Ruffato; L. Tagliavacca; R. Sitia
Imbalance between synthetic load and proteasomal capacity sensitizes normal and malignant plasma cells to proteasome inhibitors
2008-01-01 Cascio, Paolo; Bianchi, G.; Oliva, L.; Cerruti, Fulvia; Sitia, R.; Cenci, S.
Imbalance between synthetic load and proteasomal capacity sensitizes normal and malignant plasma cells to proteasome inhibitors
2008-01-01 P. Cascio; G. Bianchi; L. Oliva; F. Cerruti; R. Sitia; S. Cenci